Elon Musk’s visionary venture, Neuralink, faced a notable setback during its inaugural human brain implant trial. The device, aimed at enabling paralyzed individuals to control technology through thought, experienced detachment from the skull of the test subject, 29-year-old Noland Arbaugh. This detachment resulted in a reduction of its data capture capability.